Literature DB >> 29335451

A hot-spot mutation in CDC42 (p.Tyr64Cys) and novel phenotypes in the third patient with Takenouchi-Kosaki syndrome.

Midori Motokawa1, Satoshi Watanabe1, Akiko Nakatomi1, Tatsuro Kondoh2, Tadashi Matsumoto2, Kanako Morifuji3, Hirotake Sawada4, Toyoki Nishimura4, Hiroyuki Nunoi4, Koh-Ichiro Yoshiura5, Hiroyuki Moriuchi1, Sumito Dateki6.   

Abstract

Takenouchi-Kosaki syndrome (TKS) is a congenital malformation syndrome characterized by severe developmental delay, macrothrombocytopenia, camptodactyly, sensorineural hearing loss, and dysmorphic facial features. Recently, a heterozygous de novo mutation (p.Tyr64Cys) in the CDC42 gene, which encodes a key small GTP-binding protein of the Rho-subfamily, was identified in two unrelated patients with TKS. We herein report a third patient with TKS who had the same heterozygous CDC42 mutation. The phenotype of the patient was very similar to those of the two previously reported patients with TKS; however, she also demonstrated novel clinical manifestations, such as congenital hypothyroidism and immunological disturbance. Thus, despite the heterozygous mutation of CDC42 (p.Tyr64Cys) likely being a hot-spot mutation for TKS, its phenotype may be variable. Further studies and the accumulation of patients with CDC42 mutations are needed to clarify the phenotype in patients with TKS and the pathophysiological roles of the CDC42 mutation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29335451     DOI: 10.1038/s10038-017-0396-5

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  10 in total

Review 1.  Rho GTPases in cell biology.

Authors:  Sandrine Etienne-Manneville; Alan Hall
Journal:  Nature       Date:  2002-12-12       Impact factor: 49.962

2.  Structure of Cdc42 in complex with the GTPase-binding domain of the 'Wiskott-Aldrich syndrome' protein.

Authors:  N Abdul-Manan; B Aghazadeh; G A Liu; A Majumdar; O Ouerfelli; K A Siminovitch; M K Rosen
Journal:  Nature       Date:  1999-05-27       Impact factor: 49.962

3.  Activation of Rac-1, Rac-2, and Cdc42 by hemopoietic growth factors or cross-linking of the B-lymphocyte receptor for antigen.

Authors:  Brock Grill; John W Schrader
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

4.  Cdc42, Rac1, and the Wiskott-Aldrich syndrome protein are involved in the cytoskeletal regulation of B lymphocytes.

Authors:  L Westerberg; G Greicius; S B Snapper; P Aspenström; E Severinson
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

5.  Integrin-associated protein/CD47 regulates motile activity in human B-cell lines through CDC42.

Authors:  H Yoshida; Y Tomiyama; J Ishikawa; K Oritani; I Matsumura; M Shiraga; T Yokota; Y Okajima; M Ogawa; J i Miyagawa; T Nishiura; Y Matsuzawa
Journal:  Blood       Date:  2000-07-01       Impact factor: 22.113

6.  Macrothrombocytopenia and developmental delay with a de novo CDC42 mutation: Yet another locus for thrombocytopenia and developmental delay.

Authors:  Toshiki Takenouchi; Rika Kosaki; Takahiro Niizuma; Kenichiro Hata; Kenjiro Kosaki
Journal:  Am J Med Genet A       Date:  2015-08-06       Impact factor: 2.802

7.  Epidermal growth factor-dependent regulation of Cdc42 is mediated by the Src tyrosine kinase.

Authors:  Shine Tu; Wen Jin Wu; Jiabin Wang; Richard A Cerione
Journal:  J Biol Chem       Date:  2003-09-23       Impact factor: 5.157

8.  Rho GTPase Cdc42 is essential for B-lymphocyte development and activation.

Authors:  Fukun Guo; Chinavenmeni S Velu; H Leighton Grimes; Yi Zheng
Journal:  Blood       Date:  2009-08-11       Impact factor: 22.113

9.  Further evidence of a mutation in CDC42 as a cause of a recognizable syndromic form of thrombocytopenia.

Authors:  Toshiki Takenouchi; Nobuhiko Okamoto; Shinobu Ida; Tomoko Uehara; Kenjiro Kosaki
Journal:  Am J Med Genet A       Date:  2015-12-28       Impact factor: 2.802

10.  Thyroid bud morphogenesis requires CDC42- and SHROOM3-dependent apical constriction.

Authors:  David A F Loebel; Timothy F Plageman; Theresa L Tang; Vanessa J Jones; Maria Muccioli; Patrick P L Tam
Journal:  Biol Open       Date:  2016-01-15       Impact factor: 2.422

  10 in total
  13 in total

Review 1.  RHO GTPases: from new partners to complex immune syndromes.

Authors:  Rana El Masri; Jérôme Delon
Journal:  Nat Rev Immunol       Date:  2021-02-05       Impact factor: 53.106

2.  RNA binding protein DDX5 directs tuft cell specification and function to regulate microbial repertoire and disease susceptibility in the intestine.

Authors:  Tianyun Long; Nazia Abbasi; Juan E Hernandez; Yuxin Li; Ibrahim M Sayed; Shengyun Ma; Attilio Iemolo; Brian A Yee; Gene W Yeo; Francesca Telese; Pradipta Ghosh; Soumita Das; Wendy Jia Men Huang
Journal:  Gut       Date:  2021-12-01       Impact factor: 31.793

3.  The Growing Spectrum of Human Diseases Caused by Inherited CDC42 Mutations.

Authors:  Helen C Su; Jordan S Orange
Journal:  J Clin Immunol       Date:  2020-05       Impact factor: 8.317

4.  Progressive decline of T and B cell numbers and function in a patient with CDC42 deficiency.

Authors:  Paria Kashani; Ashish Marwaha; Stephen Feanny; Vy Hong-Diep Kim; Adelle R Atkinson; Matilde Leon-Ponte; Roberto Mendoza-Londono; Eyal Grunebaum
Journal:  Immunol Res       Date:  2021-01-06       Impact factor: 2.829

Review 5.  Rho-Family Small GTPases: From Highly Polarized Sensory Neurons to Cancer Cells.

Authors:  Takehiko Ueyama
Journal:  Cells       Date:  2019-01-28       Impact factor: 6.600

6.  Pathogenetic basis of Takenouchi-Kosaki syndrome: Electron microscopy study using platelets in patients and functional studies in a Caenorhabditis elegans model.

Authors:  Tomoko Uehara; Hidenori Suzuki; Nobuhiko Okamoto; Tatsuro Kondoh; Ayesha Ahmad; Bridget C O'Connor; Sawako Yoshina; Shohei Mitani; Kenjiro Kosaki; Toshiki Takenouchi
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

Review 7.  Actin Remodeling Defects Leading to Autoinflammation and Immune Dysregulation.

Authors:  Riccardo Papa; Federica Penco; Stefano Volpi; Marco Gattorno
Journal:  Front Immunol       Date:  2021-01-07       Impact factor: 7.561

Review 8.  Neuronal Cytoskeleton in Intellectual Disability: From Systems Biology and Modeling to Therapeutic Opportunities.

Authors:  Carla Liaci; Mattia Camera; Giovanni Caslini; Simona Rando; Salvatore Contino; Valentino Romano; Giorgio R Merlo
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

9.  A Novel CDC42 Mutation in an 11-Year Old Child Manifesting as Syndromic Immunodeficiency, Autoinflammation, Hemophagocytic Lymphohistiocytosis, and Malignancy: A Case Report.

Authors:  Aleksandra Szczawinska-Poplonyk; Rafal Ploski; Ewa Bernatowska; Malgorzata Pac
Journal:  Front Immunol       Date:  2020-03-13       Impact factor: 7.561

Review 10.  Recent advances in primary immunodeficiency: from molecular diagnosis to treatment.

Authors:  Giorgia Bucciol; Isabelle Meyts
Journal:  F1000Res       Date:  2020-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.